Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 March 2021 | Story Ruan Bruwer | Photo Netball South Africa
Defender Refiloe Nketsa is one of four Kovsies chosen for the South African U21 netball team.

With no less than four Kovsies in the South African Under 21 netball team, the near future for this sport at the University of the Free State (UFS) is certainly on the bright side.

Chanel Vrey, Refiloe Nketsa, Rolene Streutker, and Boitumelo Mahloko will be in action for the Baby Proteas, as the team is known, in a challenge series. The team will battle the President’s XII (a South African A team) and Uganda from 25 March in Cape Town. 

They all played for the Free State senior side last year. Vrey and Streutker also played for the Baby Proteas against international competition in 2019.

Mahloko – a former Kovsie – and Nketsa have also represented South Africa at junior level in the past. They were team members in the national U16 team in 2017, and a year later Mahloko made the U20 team and Nketsa the SA U18 team.

Khanyisa Chawane will also be in action in the series, playing for the Proteas, while former Kovsie captain Alicia Puren has been chosen for the President’s XII.

Meanwhile, two hockey players, Saré Laubscher and Zimkhitha Weston, have been picked for the South African U21 women’s hockey team. They would have participated in the African qualifying tournament in Ghana at the end of March. This tournament has, however, been postponed to January 2022. 

This is the third consecutive year that Laubscher has made the team. Weston, a former Kovsie, played for South Africa at the 2018 Youth Olympic Games in Argentina.

The African Hockey Qualifier serves as qualification for the Junior World Cup, which is scheduled for December in Potchefstroom. South Africa has already qualified as hosts for the Junior World Cup, but the African crown is up for grabs in Ghana. 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept